Author Index
Search or browse for an author across our entire electronic archive
Search results for: P
Results 21 - 30 of 1472 shown below
Paavonen, J
M Hinkula, E Pukkala, P Kyyrönen, P Laukkanen, P Koskela, J Paavonen, M Lehtinen and A Kauppila
A population-based study on the risk of cervical cancer and cervical intraepithelial neoplasia among grand multiparous women in Finland
doi:10.1038/sj.bjc.6601650
Abstract | Full article | PDF
-
L L Villa, R L R Costa, C A Petta, R P Andrade, J Paavonen, O-E Iversen, S-E Olsson, J Høye, M Steinwall, G Riis-Johannessen, A Andersson-Ellstrom, K Elfgren, G von Krogh, M Lehtinen, C Malm, G M Tamms, K Giacoletti, L Lupinacci, R Railkar, F J Taddeo, J Bryan, M T Esser, H L Sings, A J Saah and E Barr
High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-up
advance online publication, 2006-11-21 00:00:00.000;
doi:10.1038/sj.bjc.6603469
Abstract | Full article | PDF
Paavonen, T
O Tynninen, J Sjöström, K von Boguslawski, N O Bengtsson, R Heikkilä, P Malmström, B Østenstad, E Wist, V Valvere, E Saksela, T Paavonen and C Blomqvist
Tumour microvessel density as predictor of chemotherapy response in breast cancer patients
doi:10.1038/sj.bjc.6600325
Abstract | Full article | PDF
Pabot du Chatelard, P
A Villers, P Pommier, A Bataillard, B Fervers, J M Bachaud, N Berger, A F Bertrand, R Bouvier, D Brune, A Daver, E Fontaine, O Haillot, J L Lagrange, V Molinie, J P Muratet, P Pabot du Chatelard, M Peneau, D Prapotnich, V Ravery, P Richaud, D Rossi and M Soulie
Summary of the Standards, Options and Recommendations for the management of patients with nonmetastatic prostate cancer (2001)
doi:10.1038/sj.bjc.6601084
Abstract | Full article | PDF
Pabst, T
B U Mueller, T Pabst, P Hauser, G Gilliland, D Neuberg and D G Tenen
Mutations of the transcription factor PU.1 are not associated with acute lymphoblastic leukaemia
advance online publication, 2006-05-30 00:00:00.000;
doi:10.1038/sj.bjc.6603198
Abstract | Full article | PDF
-
B U Mueller, T Pabst, P Hauser, G Gilliland, D Neuberg and D G Tenen
Mutations of the transcription factor PU.1 are not associated with acute lymphoblastic leukaemia
doi:10.1038/sj.bjc.6603264
Abstract | Full article | PDF
-
T Pabst, M Eyholzer, J Fos and B U Mueller
Heterogeneity within AML with CEBPA mutations; only CEBPA double mutations, but not single CEBPA mutations are associated with favourable prognosis
advance online publication, 2009-03-10 00:00:00.000;
doi:10.1038/sj.bjc.6604977
Abstract | Full article | PDF
Pace, A
M Reni, F Zaja, W Mason, J Perry, E Mazza, M Spina, R Bordonaro, F Ilariucci, M Faedi, G Corazzelli, P Manno, E Franceschi, A Pace, M Candela, A Abbadessa, C Stelitano, G Latte and A J M Ferreri
Temozolomide as salvage treatment in primary brain lymphomas
advance online publication, 2007-02-27 00:00:00.000;
doi:10.1038/sj.bjc.6603660
Abstract | Full article | PDF
Pacella-Norman, R
R Pacella-Norman, M I Urban, F Sitas, H Carrara, R Sur, M Hale, P Ruff, M Patel, R Newton, D Bull and V Beral
Risk factors for oesophageal, lung, oral and laryngeal cancers in black South Africans
doi:10.1038/sj.bjc.6600338
Abstract | Full article | PDF
Pache, L
W Kuhn, B Schmalfeldt, L Pache, U Berger, K Ulm, N Harbeck, K Späthe, P Dettmar, H Höfler, F Jänicke, M Schmitt and H Graeff
Prognostic significance of urokinase (uPA) and its inhibitor PAI-1 for survival in advanced ovarian carcinoma stage FIGO IIIc
doi:10.1038/sj.bjc.6690278
Pacheco, J M
D Dingli, F A C C Chalub, F C Santos, S Van Segbroeck and J M Pacheco
Cancer phenotype as the outcome of an evolutionary game between normal and malignant cells
advance online publication, 2009-09-01 00:00:00.000;
doi:10.1038/sj.bjc.6605288
Abstract | Full article | PDF
-
D Dingli, F A C C Chalub, F C Santos, S Van Segbroeck and J M Pacheco
Reply: Evolutionary game theory: lessons and limitations, a cancer perspective
advance online publication, 2009-11-17 00:00:00.000;
doi:10.1038/sj.bjc.6605445
Paci, E
E Paci, S W Duffy, D Giorgi, M Zappa, E Crocetti, V Vezzosi, S Bianchi and M Rosselli del Turco
Quantification of the effect of mammographic screening on fatal breast cancers: The Florence Programme 1990–96
doi:10.1038/sj.bjc.6600301
Abstract | Full article | PDF
-
S Ciatto, M Rosselli Del Turco, P Burke, C Visioli, E Paci and M Zappa
Comparison of standard and double reading and computer-aided detection (CAD) of interval cancers at prior negative screening mammograms: blind review
doi:10.1038/sj.bjc.6601356
Abstract | Full article | PDF
-
S Ciatto, C Visioli, E Paci and M Zappa
Breast density as a determinant of interval cancer at mammographic screening
doi:10.1038/sj.bjc.6601548
Abstract | Full article | PDF
-
L Bucchi, A Barchielli, A Ravaioli, M Federico, V De Lisi, S Ferretti, E Paci, M Vettorazzi, S Patriarca, A Frigerio and E Buiatti
Screen-detected vs clinical breast cancer: the advantage in the relative risk of lymph node metastases decreases with increasing tumour size
advance online publication, 2004-12-14 00:00:00.000;
doi:10.1038/sj.bjc.6602289
Abstract | Full article | PDF
-
L Bucchi, A Barchielli, A Ravaioli, M Federico, V De Lisi, S Ferretti, E Paci, M Vettorazzi, S Patriarca, A Frigerio and E Buiatti
Reply: An inverse association between tumour size and overdiagnosis may explain the results by Bucchi et al
advance online publication, 2005-04-26 00:00:00.000;
doi:10.1038/sj.bjc.6602583
Abstract | Full article | PDF
-
M Zorzi, D Puliti, M Vettorazzi, V De Lisi, F Falcini, M Federico, S Ferretti, I F Moffa, L Mangone, M P Mano, C Naldoni, A Ponti, A Traina, R Tumino and E Paci
Mastectomy rates are decreasing in the era of service screening: a population-based study in Italy (1997–2001)
advance online publication, 2006-10-17 00:00:00.000;
doi:10.1038/sj.bjc.6603405
Abstract | Full article | PDF
-
D Puliti, G Miccinesi, N Collina, V De Lisi, M Federico, S Ferretti, A C Finarelli, F Foca, L Mangone, C Naldoni, M Petrella, A Ponti, N Segnan, A Sigona, M Zarcone, M Zorzi, M Zappa and E Paci
Effectiveness of service screening: a case–control study to assess breast cancer mortality reduction
doi:10.1038/sj.bjc.6604532
Abstract | Full article | PDF
-
D Puliti, G Miccinesi, N Collina, V De Lisi, M Federico, S Ferretti, A C Finarelli, F Foca, L Mangone, C Naldoni, M Petrella, A Ponti, N Segnan, A Sigona, M Zarcone, M Zorzi, M Zappa and E Paci
Effectiveness of service screening: a case–control study to assess breast cancer mortality reduction
doi:10.1038/sj.bjc.6604779
Abstract | Full article | PDF
Pacilio, C
C Pacilio, A Morabito, F Nuzzo, A Gravina, V Labonia, G Landi, E Rossi, E De Maio, M Di Maio, G D'aiuto, G Botti, N Normanno, P Chiodini, C Gallo, F Perrone and A de Matteis
Is epirubicin effective in first-line chemotherapy of metastatic breast cancer (MBC) after an epirubicin-containing adjuvant treatment? A single centre phase III trial
advance online publication, 2006-04-18 00:00:00.000;
doi:10.1038/sj.bjc.6603096
Abstract | Full article | PDF
-
Result page:
- 1|
- 2|
- 3|
- 4|
- 5|
- 6|
- 7|
- 8|
- 9|
- 10|
- 11|
- 12|
- 13|
- 14|
- 15|
- 16|
- 17|
- 18|
- 19|
- 20|
- 21|
- 22|
- 23|
- 24|
- 25|
- 26|
- 27|
- 28|
- 29|
- 30|
- 31|
- 32|
- 33|
- 34|
- 35|
- 36|
- 37|
- 38|
- 39|
- 40|
- 41|
- 42|
- 43|
- 44|
- 45|
- 46|
- 47|
- 48|
- 49|
- 50|
- 51|
- 52|
- 53|
- 54|
- 55|
- 56|
- 57|
- 58|
- 59|
- 60|
- 61|
- 62|
- 63|
- 64|
- 65|
- 66|
- 67|
- 68|
- 69|
- 70|
- 71|
- 72|
- 73|
- 74|
- 75|
- 76|
- 77|
- 78|
- 79|
- 80|
- 81|
- 82|
- 83|
- 84|
- 85|
- 86|
- 87|
- 88|
- 89|
- 90|
- 91|
- 92|
- 93|
- 94|
- 95|
- 96|
- 97|
- 98|
- 99|
- 100|
- 101|
- 102|
- 103|
- 104|
- 105|
- 106|
- 107|
- 108|
- 109|
- 110|
- 111|
- 112|
- 113|
- 114|
- 115|
- 116|
- 117|
- 118|
- 119|
- 120|
- 121|
- 122|
- 123|
- 124|
- 125|
- 126|
- 127|
- 128|
- 129|
- 130|
- 131|
- 132|
- 133|
- 134|
- 135|
- 136|
- 137|
- 138|
- 139|
- 140|
- 141|
- 142|
- 143|
- 144|
- 145|
- 146|
- 147|
- 148|
- Next
